CIPLA's weekly performance was strong, with a 3.75% return, outperforming its peers SUNPHARMA and GRASIM. However, its high volatility of 93.22% suggests a risky investment environment. Compared to its peers, CIPLA's Sharpe Ratio of 0.18 indicates a relatively low risk-adjusted return. Despite this, CIPLA's Max Drawdown of -5.65% suggests a moderate level of risk.

[Volatility: 93.22%]